The threat of delisting due to non-compliance with Nasdaq's requirements directly impacts Brüush Oral Care's standing on the exchange. This situation could lead to a decrease in investor confidence, making the stock less attractive and potentially leading to a decrease in its price in the short term. The scheduled hearing adds a timeline to the resolution or escalation of this issue, further influencing investor sentiment.